Drug intelligence / Profile preview

atorvastatin + antiretroviral therapy

Development stage
Unknown
Lead developer
Makerere University
Modality
Small Molecules
Administration
Oral
01

Overview

Atorvastatin is a small molecule HMG-CoA reductase inhibitor (statin) being investigated as an adjunct to antiretroviral therapy (ART) in the STAR trial (NCT03037372) led by Makerere University. The study evaluates the efficacy of atorvastatin in reducing chronic immune activation, systemic inflammation, and premature immune aging in HIV-infected adults in Sub-Saharan Africa. While atorvastatin is primarily indicated for hypercholesterolemia, its pleiotropic anti-inflammatory effects are hypothesized to mitigate the non-AIDS complications associated with chronic HIV infection, such as cardiovascular disease and immune exhaustion. In this context, it is typically administered orally as a daily adjunct to standard ART regimens.

Brand names
Lipitor
Other names
ART + atorvastatinSTAR trial interventionStatin Adjunct Therapy
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on atorvastatin + antiretroviral therapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on atorvastatin + antiretroviral therapy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call